Literature DB >> 2065010

Identification and characterization of a nuclear factor that specifically binds to the Rev response element (RRE) of human immunodeficiency virus type 1 (HIV-1).

Y N Vaishnav1, M Vaishnav, F Wong-Staal.   

Abstract

The Rev protein of human immunodeficiency virus type 1 (HIV-1) differentially transactivates the expression of viral structural proteins by allowing the accumulation of unspliced and singly spliced viral mRNA in the cytoplasm. The cis-acting RNA target sequence for the Rev protein, termed the Rev response element (RRE), is present in the env gene and is predicted to form a highly ordered RNA secondary structure. Recent data indicate that Rev directly binds to RRE and, further, that this binding can be mapped to a 90-nucleotide subfragment at the 5' end of RRE. We now report that RRE also binds specifically and predominantly to a nuclear factor of approximately 56 kD. Mapping of the binding site reveals that the same subfragment that binds Rev also binds this nuclear factor. We designate this protein as NFRRE for nuclear factor, RRE binding. Rev and NFRRE appear to bind simultaneously to RRE. NFRRE is widely distributed in various mammalian cells. We speculate that this factor plays an important role in Rev-mediated transactivation and is likely to be involved in the processing or transport of cellular mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065010

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  13 in total

1.  Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.

Authors:  S Venkatesan; S M Gerstberger; H Park; S M Holland; Y Nam
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein.

Authors:  E T Dayton; D A Konings; D M Powell; B A Shapiro; L Butini; J V Maizel; A I Dayton
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

3.  A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.

Authors:  O Yamada; G Kraus; L Luznik; M Yu; F Wong-Staal
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.

Authors:  G Li; J Lisziewicz; D Sun; G Zon; S Daefler; F Wong-Staal; R C Gallo; M E Klotman
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

Authors:  S W Lee; H F Gallardo; E Gilboa; C Smith
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations.

Authors:  E Berthold; F Maldarelli
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.

Authors:  T Nakaya; S Iwai; K Fujinaga; Y Sato; E Otsuka; K Ikuta
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

8.  The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent.

Authors:  B J Winslow; D Trono
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.

Authors:  H Park; M V Davies; J O Langland; H W Chang; Y S Nam; J Tartaglia; E Paoletti; B L Jacobs; R J Kaufman; S Venkatesan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency.

Authors:  S T Butera; B D Roberts; L Lam; T Hodge; T M Folks
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.